Skip to main content
Akeso, Inc. (HKG:9926)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
136.20
-0.20 (-0.15%)
Apr 29, 2026, 4:08 PM HKT

Akeso Revenue

In the year 2025, Akeso had annual revenue of 3.06B CNY with 43.90% growth. Akeso had revenue of 1.64B in the half year ending December 31, 2025, with 93.64% growth.

Revenue
3.06B CNY
Revenue Growth
+43.90%
P/S Ratio
36.89
Revenue / Employee
812.62K CNY
Employees
3,761
Market Cap
125.46B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.06B932.33M43.90%
Dec 31, 20242.12B-2.40B-53.08%
Dec 31, 20234.53B3.69B440.35%
Dec 31, 2022837.66M612.03M271.26%
Dec 31, 2021225.63M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sichuan Kelun-Biotech Biopharmaceutical 2.29B
WuXi Biologics 24.25B
Innovent Biologics 14.51B
Sino Biopharmaceutical 35.43B
RemeGen 3.62B
BeOne Medicines AG 41.59B
3SBio 19.69B
Shanghai Junshi Biosciences 2.78B
Revenue Rankings

Akeso News

More News